🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 5

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 5 of 9
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Dec 7, 2025 at 2:03 PM#21

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Dec 7, 2025 at 3:03 PM
31 4SleepFixSam, PurityPaulOR, MaxMetOK and 28 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Dec 14, 2025 at 3:15 PM#22

One thing that is still open after sean_dublin’s answer:

How long did you give it before you decided it was working?

32 5Dr.ObesityLA, NurseKim_ATL, paul_denver and 29 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Dec 21, 2025 at 4:23 PM#23
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

33 6greg_boulder, quinn_sf, NurseLeah_Nash and 30 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Dec 28, 2025 at 5:26 PM#24
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

Last edited: Dec 28, 2025 at 8:26 PM
34 7LarryQC_SD, wanda_boise, NurseAsh_DET and 31 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Jan 4, 2026 at 6:26 PM#25
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

Genuinely useful, thank you. I had the facts and not the framework.

35 8RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 32 others
Reply Quote Save Share Report
1345679

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register